Home | News | Overview | Our Residents | Why LMC? | Our IM Faculty | Our Graduates | For More Information | About the Region | Fellowships | Photos | Links

Internal Medicine and Fellowship Programs

Lane Ziegler, D.O., F.A.C.O.I.

 
Lane Ziegler, D.O., F.A.C.O.I.
HEMATOLOGY/ONCOLOGY
EDUCATION
Undergraduate: Northeast Missouri State University (Kirksville, Missouri)
 
Medical School: Kirksville College of Osteopathic Medicine
 
Internship: Grandview Hospital
 
Residency: Internal Medicine, Grandview Hospital
 
Fellowship: Medical Oncology, The University of Texas M.D. Anderson Cancer Center
 
PUBLICATIONS
Ziegler LD, Buzdar AU: Current Status of Adjuvant Therapy of Early Breast Cancer.  American Journal of Clinical Oncology.  1991; 14 (2) : 101 - 110.
 
Ziegler LD, COnnelly J, Frye D, Smith TL, Hortobagyi GN: Lack of Correlation Between Histology and Response to Chemotherapy in Metastatic Breast Cancer.  Cancer.  1991; 68 : 628 - 633.
 
Ziegler LD, Buzdar JL: Recent Advances in the Treatment of Breast Cancer.  American Journal of Medical Science.  1991; 301 (5) : 337 - 352.
 
Ziegler LD, Murray JL: Monoclonal Antibodies in the Treatment of Malignancy: Rationale for Combined Treatment with Other Biological Modifiers.  Cancer Bulletin.  1991; 43(3).
 
Ziegler LD, Kroll S: Primary Breast Cancer After Prophylactic Mastectomy.  American Journal of Clinical Oncology.  1991; 14(5) : 451 - 454.
 
Ziegler LD, Palazzalo P, Cunningham J, et. al: Phase I Trial of Murine Monoclonal Antibody L6 in Combination with Subcutaneous Interleukin-2 in Patients with Advanced Carcinoma of the Breast, Colorectum, and Lumg.  Journal of Clinical Oncology.  1992; 10: 1470 - 1478.
 
Goodman GE, Murry JL, Hellstron KE, Miccaise C, Yelton D, Palasollo P, Ziegler LD, Hellstron I: Phase I Trial of Chimeric Monoclonal Antibody L6 (ChL6).  Proceedings of The American Association of Cancer Research.  1990: Abstract #1035: 61.